Mast Cells and Fibrosis. The Relevance to Scleroderma
Overview
Authors
Affiliations
Mast cells are being recognized as important constituents in fibrotic processes. This article reviews the evidence for increased mast cell numbers and/or function in a variety of fibrotic conditions. Increased mast cell numbers and activity are seen in chronic murine graft-versus-host disease (a model for scleroderma) and in active scleroderma itself. An integrated schema for scleroderma is presented, emphasizing the interactions among mast cells, endothelial cells, and fibroblasts mediated by heparin and heparin-binding growth factors.
PAI1 mediates fibroblast-mast cell interactions in skin fibrosis.
Pincha N, Hajam E, Badarinath K, Batta S, Masudi T, Dey R J Clin Invest. 2018; 128(5):1807-1819.
PMID: 29584619 PMC: 5919880. DOI: 10.1172/JCI99088.
Shrestha S, Wershil B, Sarwark J, Niewold T, Philipp T, Pachman L Arthritis Rheum. 2010; 62(9):2813-22.
PMID: 20506305 PMC: 3312790. DOI: 10.1002/art.27529.
Mast cells and immunological skin diseases.
Navi D, Saegusa J, Liu F Clin Rev Allergy Immunol. 2007; 33(1-2):144-55.
PMID: 18094953 DOI: 10.1007/s12016-007-0029-4.
Human mast cells produce type VIII collagen in vivo.
Ruger B, Dunbar P, Hasan Q, Sawada H, Kittelberger R, Greenhill N Int J Exp Pathol. 1994; 75(6):397-404.
PMID: 7734329 PMC: 2001916.
Postlethwaite A, Seyer J J Clin Invest. 1991; 87(6):2147-52.
PMID: 2040697 PMC: 296973. DOI: 10.1172/JCI115247.